Publication:
Nilotinib results in improved rates of molecular response in Turkish newly diagnosed CML-CP patients: A 24-month update

dc.contributor.authorSaydam, G.
dc.contributor.authorHaznedaroğlu, I. C.
dc.contributor.authorKaynar, L.
dc.contributor.authorYavuz, A. S.
dc.contributor.authorAli, Rıdvan
dc.contributor.authorGüvenç, B.
dc.contributor.authorAkay, O. M.
dc.contributor.authorBaşlar, Z.
dc.contributor.authorÖzbek, U.
dc.contributor.authorSönmez, M.
dc.contributor.authorAydın, D.
dc.contributor.authorPehlivan, M.
dc.contributor.authorUndar, B.
dc.contributor.authorDağdaş, S.
dc.contributor.authorAyyıldız, O. M.
dc.contributor.authorUar, B.
dc.contributor.authorDağ, I. M.
dc.contributor.authorİlhan, O.
dc.contributor.buuauthorALİ, RIDVAN
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı
dc.contributor.researcheridGXD-8209-2022
dc.date.accessioned2024-08-09T04:58:18Z
dc.date.available2024-08-09T04:58:18Z
dc.date.issued2015-06-01
dc.descriptionBu çalışma, 11-14, Haziran 2015 tarihlerinde Vienna[Avusturya]’da düzenlenen 20. Congress of European-Hematology-Association Kongresi‘nde bildiri olarak sunulmuştur.
dc.identifier.endpage696
dc.identifier.issn0390-6078
dc.identifier.startpage695
dc.identifier.urihttps://hdl.handle.net/11452/43827
dc.identifier.volume100
dc.identifier.wos000361204904296
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherFerrata Storti Foundation
dc.relation.journalHaematologica
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectHematology
dc.titleNilotinib results in improved rates of molecular response in Turkish newly diagnosed CML-CP patients: A 24-month update
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication578cac50-ce4d-4818-8e99-2634ef340753
relation.isAuthorOfPublication.latestForDiscovery578cac50-ce4d-4818-8e99-2634ef340753

Files

Collections